Thiazolidinediones, deadly sins, surrogates, and elephants

被引：26

作者：

Cleland, John G. F. ^{[1
]}

Atkin, Stephen L.

机构：

[1] Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, N Humberside, England

[2] Hull York Med Sch, Dept Diabet, Kingston Upon Hull, N Humberside, England

来源：

LANCET | 2007年 / 370卷 / 9593期

关键词：

D O I：

10.1016/S0140-6736(07)61488-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1103 / 1104

页数：2

共 11 条

[1] Surrogate end points in heart failure [J].

Anand, IS ;

Florea, VG ;

Fisher, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (09) :1414-1421

[2] Atenolol in hypertension: is it a wise choice? [J].

Carlberg, B ;

Samuelsson, O ;

Lindholm, LJ .

LANCET, 2004, 364 (9446) :1684-1689

[3] Prognosis in heart failure with a normal ejection fraction [J].

Cleland, John G. F. ;

Taylor, Jacqueline ;

Tendera, Michal .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08) :829-830

[4] Clinical trials update from the American college of cardiology: darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND [J].

Cleland, John G. R. ;

Coletta, Alison P. ;

Nikitin, Nikolay P. ;

Clark, Andrew L. .

EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (03) :326-329

[5] A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association functional class I or II heart failure [J].

Dargie, Henry J. ;

Hildebrandt, Per R. ;

Riegger, Guenter A. J. ;

McMurray, John J. V. ;

McMorn, Stephen O. ;

Roberts, Jeremy N. ;

Zambanini, Andrew ;

Wilding, John P. H. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (16) :1696-1704

[6] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[7] Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [J].

Home, Philip D. ;

Pocock, Stuart J. ;

Beck-Nielsen, Henning ;

Gomis, Ramon ;

Hanefeld, Markolf ;

Jones, Nigel P. ;

Komajda, Michel ;

McMurray, John J. V. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :28-38

[8] Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials [J].

Lago, Rodrigo M. ;

Singh, Premranjan P. ;

Nesto, Richard W. .

LANCET, 2007, 370 (9593) :1129-1136

[9] Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].

Nissen, Steven E. ;

Wolski, Kathy .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471

[10] Effect of torcetrapib on the progression of coronary atherosclerosis [J].

Nissen, Steven E. ;

Tardif, Jean-Claude ;

Nicholls, Stephen J. ;

Revkin, James H. ;

Shear, Charles L. ;

Duggan, William T. ;

Ruzyllo, Witold ;

Bachinsky, William B. ;

Lasala, Gregory P. ;

Tuzcu, E. Murat .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) :1304-1316

← 1 2 →